Shah Smital

Lyell Immunopharma, Inc. · Chief Fin. and Bus. Officer

Shah Smital is listed in public filings as officer: Chief Fin. and Bus. Officer. This Shah Smital insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Lyell Immunopharma, Inc. (LYEL), and Pliant Therapeutics, Inc. (PLRX). Investors use Shah Smital's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Lyell Immunopharma, Inc.LYEL$3.6M140k sharesGrant / ExerciseMar 9, 2026$3.6M140k shares$25.50--

Insider Trades History

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Pliant Therapeutics, Inc.PLRX$350k26.8k sharesGrant / ExerciseJun 13, 2024$349.5K26.8k shares$13.06--